Literature DB >> 29026064

The Effect of Recipient Body Mass Index and Its Extremes on Survival and Graft Vascular and Biliary Complications After Liver Transplantation: A Single Center Retrospective Study.

Emmanouil Giorgakis1,2, Michele Tedeschi1, Eliano Bonaccorsi-Riani1, Shirin Elizabeth Khorsandi3, Krishna Menon4, Hector Vilca-Melendez1, Wayel Jassem1, Parthi Srinivasan1, Andreas Prachalias1, Nigel Heaton1.   

Abstract

BACKGROUND This is the largest UK-based study on the effect of recipient body mass index (BMI) and its extremes (BMI <18.5 and BMI ≥35 kg/m²) on liver transplant (LT) outcomes. Its purpose was to analyze the BMI effect on post-LT mortality, graft loss, primary non-function (PNF), and graft vascular and biliary complications. MATERIAL AND METHODS Data were retrieved from a single-center LT database of 2,115 consecutive patients receiving first LT during period February 2004 to September 2015. Survivals were compared across the BMI groups; the effects of recipient BMI on survival, PNF, and graft vascular and biliary complications were analyzed via regression. RESULTS Autoimmune disease and nonalcoholic steatohepatitis were prevalent among underweight and morbidly obese adults, respectively. Graft survival was similar across BMI classes at 30 days and in 1, 2, 5, and 10 years (p=0.75) and on obese versus non-obese (p=0.33). BMI <35 kg/m² versus BMI ≥35 kg/m² mean graft survival was similar (p=0.84). BMI <18.5 kg/m² recipients tended to have inferior mean graft and patient survivals; however, the difference was non-significant (p=0.09 and p=0.1 respectively). BMI <18.5 kg/m² recipients were at higher risk of hepatic artery thrombosis (HR, 1.73, 95% CI 1.73-3, p<0.05). Adult underweight status was an independent HAT risk factor (HR 3, 95% CI 1-8.6, p=0.046). BMI class did not affect ischemic cholangiopathy risk (p=0.84). However, the overall biliary complication risk increased by 3% for every 1 kg/m² BMI rise. CONCLUSIONS Post-LT survival is independent of recipient BMI. Underweight status is linked to higher HAT risk. Biliary complication risk increases with rising recipient BMI. After appropriate recipient selection, recipient BMI extremes are not a contraindication for LT.

Entities:  

Mesh:

Year:  2017        PMID: 29026064     DOI: 10.12659/aot.903475

Source DB:  PubMed          Journal:  Ann Transplant        ISSN: 1425-9524            Impact factor:   1.530


  6 in total

1.  Living Donor Liver Transplantation in a Cohort of Recipients With Left Ventricular Systolic Dysfunction.

Authors:  Pooja Bhangui; Prashant Bhangui; Manish Aneja; Nishant Sharma; Nikunj Gupta; A S Soin; Vijay Vohra
Journal:  J Clin Exp Hepatol       Date:  2022-03-16

Review 2.  Optimizing patients with non-alcoholic fatty liver disease pre-transplant.

Authors:  Amine Benmassaoud; Marc Deschenes; Tianyan Chen; Peter Ghali; Giada Sebastiani
Journal:  Can Liver J       Date:  2020-08-20

3.  High visceral adipose tissue area is independently associated with early allograft dysfunction in liver transplantation recipients: a propensity score analysis.

Authors:  Guanjie Yuan; Shichao Li; Ping Liang; Gen Chen; Yan Luo; Yaqi Shen; Xuemei Hu; Daoyu Hu; Jiali Li; Zhen Li
Journal:  Insights Imaging       Date:  2022-10-11

Review 4.  Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges.

Authors:  Naga Swetha Samji; Rajanshu Verma; Krishna Chaitanya Keri; Ashwani K Singal; Aijaz Ahmed; Mary Rinella; David Bernstein; Manal F Abdelmalek; Sanjaya K Satapathy
Journal:  Dig Dis Sci       Date:  2019-07-16       Impact factor: 3.199

5.  Liver Transplantation in Recipients With Class III Obesity: Posttransplant Outcomes and Weight Gain.

Authors:  Daiki Soma; Yujin Park; Plamen Mihaylov; Burcin Ekser; Marwan Ghabril; Marco Lacerda; Naga Chalasani; Richard S Mangus; Chandrashekhar A Kubal
Journal:  Transplant Direct       Date:  2022-01-05

6.  Feasible management of median arcuate ligament syndrome in orthotopic liver transplantation recipients.

Authors:  Shu-Xuan Li; Ye-Hui Fan; Guang-Yao Tian; Guo-Yue Lv
Journal:  World J Gastrointest Surg       Date:  2022-09-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.